title: Preventing pregnancy loss.
abstract: In this issue of Blood, 2 articles by The Nimes Obstetricians and Hematologists–Antiphospholipid Syndrome (NOH-APS) Study Group give us new information about the effects of low-molecular-weight heparin (LMWH) on pregnancy complications in women with prior pregnancy loss and either purely obstetric antiphospholipid syndrome (APS) or inherited thrombophilia. The results better define women at risk, suggest a role for LMWH, and confirm the need for further investigation.
authors.affiliation: BRIGHAM AND WOMEN'S HOSPITAL;
authors.forename: Jean M
authors.initials: JM
authors.lastname: Connors
mesh_terms: D000026:Abortion, Habitual / Q000453:epidemiology*; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D016736:Antiphospholipid Syndrome / Q000453:epidemiology* / Q000628:therapy*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology* / Q000628:therapy*; D011250:Pregnancy Complications, Hematologic / Q000453:epidemiology*; D019851:Thrombophilia / Q000150:complications* / Q000453:epidemiology*
chemical_list: D017152:Antibodies, Antiphospholipid